The choice isn't between safe and risky—it's between two risks
In the long history of medicine, few tensions run deeper than the one between what a patient fears and what a patient needs. Marion Tunnicliffe of Southport found herself caught in that gap — a woman with serious heart disease who set aside her statins after reading a warning leaflet, without anyone to help her weigh documented risk against documented benefit. Her story, addressed by Dr. Martin Scurr, is less about one medication and more about what happens when the conversation between doctor and patient is replaced by a legal document and a five-minute appointment.
- A patient with atrial fibrillation and a pacemaker stopped taking life-extending statins because no one explained that the warning leaflet was written for lawyers, not for her.
- Drug information sheets, mandatory since the 1990s, catalogue every conceivable side effect across every possible patient — a necessary legal shield that, without context, can read like a threat.
- The five-minute GP appointment is doing real harm: when there is no time to translate medical evidence into human terms, fear fills the silence and patients make decisions alone.
- A second patient suspects her headaches and dizziness are caused by mobile phone radiation, but controlled studies show that self-identified electrohypersensitive people cannot reliably detect actual exposure — pointing toward anxiety rather than physics.
- Both cases land in the same place: the distance between clinical knowledge and patient understanding is not a footnote problem, it is a health crisis in miniature.
Marion Tunnicliffe from Southport read the warning leaflet that came with her statin prescription and decided the risks outweighed the benefits. She switched to omega-3 and collagen supplements, hoping to manage her cholesterol naturally. When she eventually tried the statins again, she experienced sharp pains down one side of her body and stopped for good.
What the leaflet did not tell her — and what no one in a rushed five-minute appointment apparently did either — is that she has atrial fibrillation and a pacemaker. For someone with that degree of underlying heart disease, raised cholesterol is not an abstract number. It is a direct and measurable threat. The clinical evidence is unambiguous: patients with heart disease who take statins live longer.
Dr. Martin Scurr's response places the blame not on the medication but on the information vacuum surrounding it. Drug leaflets, legally required since the 1990s, are designed to list every possible side effect in every possible person, however rare. They protect manufacturers from liability. They are not designed to help an individual patient weigh her specific risks — and without a doctor to provide that context, they can do more harm than good. Scurr offers a simple analogy: car manuals document that people die in cars, yet we drive. The benefits, understood in context, outweigh the risks.
A second letter, from S. Hill in London, describes headaches and dizziness that appear when using a mobile phone and disappear when it is switched off. Hill suspects electrohypersensitivity. Scurr acknowledges her symptoms are real and distressing, but notes that the World Health Organisation finds little scientific evidence for the condition as a distinct medical entity. Controlled studies show that people who believe themselves sensitive to radiofrequency radiation cannot reliably detect when they are actually being exposed to it — suggesting the symptoms may be rooted in expectation or anxiety rather than radiation itself.
Scurr does not dismiss her. If avoiding certain devices improves her quality of life, he sees no harm in it. He suggests removing one device at a time and reintroducing it methodically to identify any genuine trigger. Both letters, taken together, point toward the same quiet crisis: the gap between what medicine knows and what patients are helped to understand, and the cost of leaving people alone to navigate that distance.
Marion Tunnicliffe from Southport had a problem that many patients face: she read the warning label on her statin prescription and decided the risks weren't worth it. The information sheet spelled out potential side effects and recommended a low-cholesterol diet, so she started taking omega-3 and collagen supplements instead, thinking she could manage her high cholesterol without the medication. When she finally did take the statins—after a second doctor assured her the warnings were just legal cover—she experienced sharp pains running down one side of her body. That was enough. She stopped taking them.
But Tunnicliffe's case, as Dr. Martin Scurr points out in his response, involves more than just statin anxiety. In her full letter, she mentions having atrial fibrillation, a heart rhythm disorder, and a pacemaker—markers of serious underlying heart disease. For someone in her position, raised cholesterol isn't an abstract health number. It's a direct threat. The evidence is clear: patients prescribed statins after a heart disease diagnosis live longer. The medication works.
The real culprit in Tunnicliffe's story isn't the statin itself but the five-minute GP appointment she describes. No one took time to walk her through what the warnings actually meant, or to help her weigh the genuine risks of the medication against the much larger risk of a heart attack or stroke. Drug information leaflets, legally required since the 1990s, are designed to cover every possible side effect in every possible person—some common, many extraordinarily rare. They exist partly to inform patients and partly to protect manufacturers from liability. It's a necessary legal framework, but it can terrify people who read it alone, without context.
Scurr offers a useful analogy: if every car came with a user manual stating that people die in cars, we wouldn't stop driving. We'd simply accept that the benefits outweigh the documented risks. The same logic applies to medication. A low-cholesterol diet, he explains, means cutting back on red meat and full-fat dairy while increasing soluble fiber from foods like oats and beans. These changes, combined with statins, form the standard approach to managing cholesterol in someone with existing heart disease.
The column also addresses a second patient, S. Hill from London, who experiences headaches and dizziness when using a mobile phone but feels fine when it's off. Hill suspects electrohypersensitivity—a condition in which people believe radiofrequency radiation from phones and wireless devices triggers physical symptoms. Scurr acknowledges that Hill's symptoms are real and distressing. But he also cites the World Health Organisation's position: there is little scientific evidence that electrohypersensitivity exists as a distinct medical condition.
The research is telling. When scientists have exposed some people to actual radiofrequency radiation and others to fake exposure—without telling participants which group they're in—those who believed themselves sensitive haven't consistently reported more symptoms. In fact, studies show that electrohypersensitive people cannot reliably detect when they're actually being exposed to the radiation. This suggests the symptoms, while genuine, may stem from anxiety or expectation rather than the radiation itself.
Still, Scurr doesn't dismiss Hill's experience. If avoiding phones and wi-fi routers improves her quality of life, there's no harm in doing so, even if science hasn't yet validated the mechanism. He suggests eliminating one device at a time and reintroducing it to identify which, if any, triggers the symptoms. The practical advice sidesteps the larger debate: sometimes people need permission to manage their health in ways that feel right to them, even when the science remains uncertain.
Both letters point to the same underlying issue—the gap between what doctors know and what patients understand, and the importance of closing that gap through conversation rather than leaving people alone with their fears and their warning labels.
Citações Notáveis
Raised cholesterol is a significant risk for a heart attack or stroke, which is why we prescribe statins alongside dietary changes.— Dr. Martin Scurr
There is no doubt your symptoms are genuine. Nevertheless, I agree with the World Health Organisation that there is little scientific evidence for electrohypersensitivity.— Dr. Martin Scurr
A Conversa do Hearth Outra perspectiva sobre a história
Why did Tunnicliffe refuse the statins in the first place? The warnings on the leaflet?
Partly, yes. But it was also that no one explained to her why she needed them. She has a pacemaker and atrial fibrillation—serious heart disease. For her, statins aren't optional. But she was left to read the leaflet alone and make sense of it.
And when she did take them, she got side effects. Pains down one side. Doesn't that prove the warnings are real?
It does. Side effects are real. But so is the fact that people with her condition live longer on statins. The choice isn't between a safe option and a risky one. It's between two risks, and she needs to understand both.
What about the electrohypersensitivity patient? Is that real or not?
The symptoms are real. The person genuinely feels dizzy and gets headaches. But when scientists test whether people can actually detect the radiation causing it, they can't—not consistently. It's one of those cases where the experience is true but the explanation might not be.
So Scurr is saying it's all in her head?
No. He's saying the symptoms are genuine but probably not caused by the radiation itself. Anxiety can produce real physical symptoms. That doesn't make them less real, just differently understood.
And his advice is just to avoid the phones anyway?
Yes. If it helps her feel better, there's no cost to avoiding them. But he's also suggesting she test it methodically—remove one device, see if symptoms improve, add it back. That's how you actually figure out what's happening.